Please use this identifier to cite or link to this item: https://doi.org/10.3390/pharmaceutics13111790
DC FieldValue
dc.titleNanoencapsulation as a General Solution for Lyophilization of Labile Substrates
dc.contributor.authorVallerinteavide Mavelli, Girish
dc.contributor.authorSadeghi, Samira
dc.contributor.authorVaidya, Siddhesh Sujit
dc.contributor.authorKong, Shik Nie
dc.contributor.authorDrum, Chester Lee
dc.date.accessioned2022-01-14T09:24:41Z
dc.date.available2022-01-14T09:24:41Z
dc.date.issued2021-11-01
dc.identifier.citationVallerinteavide Mavelli, Girish, Sadeghi, Samira, Vaidya, Siddhesh Sujit, Kong, Shik Nie, Drum, Chester Lee (2021-11-01). Nanoencapsulation as a General Solution for Lyophilization of Labile Substrates. PHARMACEUTICS 13 (11). ScholarBank@NUS Repository. https://doi.org/10.3390/pharmaceutics13111790
dc.identifier.issn19994923
dc.identifier.urihttps://scholarbank.nus.edu.sg/handle/10635/213876
dc.description.abstractProtein macromolecules occur naturally at the nanoscale. The use of a dedicated nanoparti-cle as a lyophilization excipient, however, has not been reported. Because biopolymeric and lipid nanoparticles often denature protein macromolecules and commonly lack the structural rigidity to survive the freeze-drying process, we hypothesized that surrounding an individual protein substrate with a nanoscale, thermostable exoshell (tES) would prevent aggregation and protect the substrate from denaturation during freezing, sublimation, and storage. We systematically investigated the properties of tES, including secondary structure and its homogeneity, throughout the process of lyophilization and found that tES have a near 100% recovery following aqueous reconstitution. We then tested the hypothesis that tES could encapsulate a model substrate, horseradish peroxidase (HRP), using charge complementation and pH-mediated controlled assembly. HRP were encapsulated within the 8 nm internal tES aqueous cavity using a simplified loading procedure. Time-course experiments demonstrated that unprotected HRP loses 95% of activity after 1 month of lyophilized storage. After encapsulation within tES nanoparticles, 70% of HRP activity was recovered, represent-ing a 14-fold improvement and this effect was reproducible across a range of storage temperatures. To our knowledge, these results represent the first reported use of nanoparticle encapsulation to stabilize a functional macromolecule during lyophilization. Thermostable nanoencapsulation may be a useful method for the long-term storage of labile proteins.
dc.language.isoen
dc.publisherMDPI
dc.sourceElements
dc.subjectScience & Technology
dc.subjectLife Sciences & Biomedicine
dc.subjectPharmacology & Pharmacy
dc.subjectlyophilization
dc.subjectfreeze-drying
dc.subjectthermostable exoshells
dc.subjecttES
dc.subjectHRP
dc.subjectENZYME ENCAPSULATION
dc.subjectMONOCLONAL-ANTIBODY
dc.subjectSELF-ASSOCIATION
dc.subjectDRUG-DELIVERY
dc.subjectSTABILITY
dc.subjectPROTEINS
dc.subjectSTABILIZATION
dc.subjectSUGARS
dc.subjectFORMULATION
dc.subjectMECHANISMS
dc.typeArticle
dc.date.updated2022-01-13T08:26:48Z
dc.contributor.departmentMEDICINE
dc.description.doi10.3390/pharmaceutics13111790
dc.description.sourcetitlePHARMACEUTICS
dc.description.volume13
dc.description.issue11
dc.published.statePublished
Appears in Collections:Staff Publications
Elements

Show simple item record
Files in This Item:
File Description SizeFormatAccess SettingsVersion 
Nanoencapsulation as a General Solution for Lyophilization of Labile Substrates.pdf1.76 MBAdobe PDF

OPEN

PublishedView/Download

Google ScholarTM

Check

Altmetric


Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.